Companies & People
Cary’s Heron Therapeutics agrees to asset sale valued at $222.6 million
CARY - Heron Therapeutics has agreed to sell substantially all of its operating assets to CorMedix Therapeutics in a transaction valued at about $222.6 million upfront when announced,…